A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients
Condition:   Friedreich Ataxia Interventions:   Drug: MIN-102;   Drug: Placebo Sponsor:   Minoryx Therapeutics, S.L. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2019 Category: Research Source Type: clinical trials